Crown pharmaceutical

Active Blanket Purchase Agreement Awarded Last action

Contract number
HT001426AE005
Awardee
Awarding agency
Task orders
1 $25,000 obligated

Award facts

Combined order value
$25,000 Current and potential, with all options
Last date to order 15% complete
IDV ceiling 5% used
$500,000.00
Maximum order
$25,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Crown Pharmaceuticals Inc., a woman-owned small business based in Elmwood, Louisiana, was awarded a single-award Blanket Purchase Agreement by the Defense Health Agency with a ceiling value of $500,000 and a performance period extending from January 12, 2026 through January 11, 2031. The contract encompasses secondary pharmaceutical drug supplies and related medical materials to support federal healthcare operations. No specific set-aside provisions were applied to this award. Based on the vendor's historical performance under prior indefinite-delivery, indefinite-quantity vehicles with the Indian Health Service, Crown Pharmaceuticals demonstrates established capability in sourcing and delivering pharmaceutical supplies, medical equipment, and sanitation products to federal healthcare facilities, with performance locations historically centered in Oklahoma City and New Orleans.

Under this Blanket Purchase Agreement structure, the Defense Health Agency will issue individual task orders against the $500,000 ceiling to procure specific pharmaceutical drug supplies and secondary medical products as operational requirements dictate. The indefinite-delivery mechanism allows the government to maintain supply chain flexibility while leveraging Crown Pharmaceuticals' vendor capabilities and established distribution infrastructure. The contractor's track record includes successful delivery of firm fixed-price pharmaceutical and medical supply products to healthcare facilities serving federal beneficiary populations, positioning the company to fulfill variable demand requirements throughout the five-year contract period. This BPA arrangement provides the Defense Health Agency with pre-negotiated pricing and expedited procurement authority for critical pharmaceutical supplies without requiring full competition for each individual task order.

Task orders

Task order Ordering agency Obligated Awarded
Crown pharmaceutical HT001426FE044 Defense Health Agency $25,000

Quick answers

Who was awarded contract HT001426AE005?

HT001426AE005 was awarded to Crown Pharmaceuticals Inc. by Defense Health Agency (Department of Defense) on January 12, 2026.

How much is contract HT001426AE005 worth?

Orders under HT001426AE005 have obligated $25,000. HT001426AE005's own ceiling is $500,000. A single order can be worth up to $25,000.

How many orders have been placed under contract HT001426AE005?

1 order has been placed under HT001426AE005, the latest on April 6, 2026.

Who can order from contract HT001426AE005?

HT001426AE005 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV